Empyrean Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$65.1M |
| 2 |
Visa
V
|
+$48.5M |
| 3 |
MW
THE MENS WAREHOUSE INC
MW
|
+$36M |
| 4 |
Air Products & Chemicals
APD
|
+$34.4M |
| 5 |
Vodafone
VOD
|
+$34.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Occidental Petroleum
OXY
|
+$176M |
| 2 |
Lamar Advertising Co
LAMR
|
+$91.4M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$86.3M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$69.8M |
| 5 |
AerCap
AER
|
+$57.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 71.06% |
| 2 | Communication Services | 5.09% |
| 3 | Financials | 4.91% |
| 4 | Energy | 4.58% |
| 5 | Materials | 4.14% |
Similar funds
Empyrean Capital Partners's Q1 2014 Portfolio in Review
As of Q1 2014, Empyrean Capital Partners held 65 positions worth $2.62B, down 7.8% from $2.84B the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Empyrean Capital Partners withdrew a net $526M in Q1 2014, closing 23 positions and reducing 4 holdings. Its most notable exit was Occidental Petroleum, an estimated $176M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, up from 61% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Empyrean Capital Partners opened a new position in Visa worth $47.1M.
- Empyrean Capital Partners's largest Q1 2014 buy was Visa: 873,200 shares worth $47.1M.
- Empyrean Capital Partners added most to UnitedHealth in Q1 2014, an estimated $65.1M increase.
- Empyrean Capital Partners's biggest Q1 2014 reduction was TYCO INTL PLC COM SHS (IRL), cutting an estimated $69.8M.
- Empyrean Capital Partners fully exited Occidental Petroleum in Q1 2014, selling an estimated $176M.
- Empyrean Capital Partners's ten largest holdings make up 77% of its $2.62B portfolio in Q1 2014.
- Empyrean Capital Partners opened 15 new positions and closed 23 in Q1 2014.
- Empyrean Capital Partners's portfolio value fell 7.8% quarter-over-quarter to $2.62B.
Based on Empyrean Capital Partners's 13F filing for Q1 2014, filed 14 May 2014.